1-5 of 5
Amro Elshoury, MBBChir
Close
Save search
Sort by
Journal Articles

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Free
Ang Li, MDMS, Nicole M. Kuderer, MD MSc, Jeremy L. Warner, MD MS, Aakash Desai, MD, Dimpy P. Shah, MD PhD, Julie Fu, MD MA, Monica Li, Rebecca Zon, Surbhi Shah, MD, Shuchi Gulati, MD, Ali Raza Khaki, MD, Amit Kulkarni, MD, Amro Elshoury, MBBChir, Michael A. Thompson, MD PhD, Petros Grivas, MD PhD, Gilberto de Lima Lopes, MD MBA, Yu Shyr, PhD, Nathan A Pennell, MD PhD, Andrew Schmidt, MD, Christopher R Friese, Daniel Stover, Jaymin Patel, Balazs Halmos, Toni K. Choueiri, MD, Solange Peters, MD, Donna R. Rivera, PharmD, Corrie Painter, PhD, Brian Rini, MD, Gary H. Lyman, MD, Jean M. Connors, MD, Rachel P. Rosovsky, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 56–58.
https://doi.org/10.1182/blood-2020-138834
Published: 2020
Journal Articles

Phase 1/1b Trial of Talazoparib and Gemtuzumab Ozogamicin in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia

Free
Amanda Przespolewski, DO, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Amro Elshoury, MBBChir, Ashkan Emadi, MD, PhD, Vu H. Duong, MD, Sandrine Niyongere, MD, Wendy Walinski, Meriem Said, Stephanie Halliwell, Kemji Eke, Kristopher Attwood, PhD, Maria R. Baer, MD, Eunice S. Wang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-141736
Published: 2020
Journal Articles

Outcomes of AML Patients Treated with Gemtuzumab-Ozogamicin Based Therapies: A Cue to Optimal Chemotherapy Backbone

Free
Swapna Thota, MD, Abhay Singh, MBBS,MPH, Sarah Sadek, MD, Mark G. Faber, DO, Jeffrey Baron, PharmD, Amro Elshoury, MBBChir, James E. Thompson, MD, Amanda Przespolewski, DO, Elizabeth A. Griffiths, MD, Eunice S. Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2645.
https://doi.org/10.1182/blood-2019-131633
Published: 2019
Journal Articles

Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid Leukemia

Free
Amanda Przespolewski, DO, Craig W. Freyer, PharmD, Wenyan Ji, MA, Tara L. Cronin, BA, Swapna Thota, MD, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Amro Elshoury, MBBChir, Jeffrey Baron, PharmD, Mark Walsh, PharmD, Eunice S. Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1361.
https://doi.org/10.1182/blood-2019-130582
Published: 2019
Journal Articles

Cyclosporine May Inhibit the Effect of Extra-Physiologic Oxygen Shock/Stress on Peripheral Blood Stem Cells

Free
Amro Elshoury, MBBChir, Hans Minderman, PhD, Alexis Conway, PhD, Paul K. Wallace, MS, PhD, Charlie Mantel, Joseph Dennis Tario, PhD, Yeong Choi, Kieran O'Loughin, MS, Carlos Cedeno, PhD, Jenna Nichols, Kahteong Soh, MS, Philip L. McCarthy, MD, George Chen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3346.
https://doi.org/10.1182/blood-2018-99-119329
Published: 2018